Delivery Order SPE2DR25D7064-SPE2DR26F2MRH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $24,256.99 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 tablets (21-count packages) on December 8, 2025, with an ultimate completion date of December 9, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,718.66 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of July 18, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor, is executing this order as a child contract under its broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,898.32 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1-20 tablets (21-count packages) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Loestrin 21 1-20 Tablet in quantities of 21 tablets, with a contract ceiling value of $2,983.50 and a firm fixed price structure. The contract is non-set-aside and represents a competitive award for pharmaceutical supply. This delivery order is completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.58 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablet (21-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award, which received no set-aside designation, represents a firm fixed-price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packaging) under a firm fixed-price contract with a ceiling value of $1,074.58. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,121.57 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loestrin 21 1.5-30 tablets (21-count packages). This is a firm fixed price delivery order with no set-aside designation, representing a competitively awarded contract. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This award is...
- The Defense Logistics Agency awarded a $26,310.76 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Loestrin 21 1-20 Tablet in quantities of 21 tablets per unit. This is a firm fixed-price contract with no set-aside designation, utilizing open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 24, 2025. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Loestrin 21 1-20 tablets (21-count packages) under a firm fixed-price contract with a ceiling value of $6,270.38. This non-set-aside competitive award is classified as a delivery order and has an ultimate completion date of November 6, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,816.41 to AmerisourceBergen Drug Corp for the supply of Loestrin 21 1.5-30 tablets (21-count package). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- SPE2DR25D7064Indefinite Delivery Contract
- SPE2DR25D7064-SPE2DR26F2MRHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,155.38 on December 10, 2025, for Loestrin 21 1-20 Tablet (21-count units). This non-competitive delivery order, with a firm fixed price structure, represents a routine pharmaceutical procurement through the company's existing contract vehicle. The place of performance is listed as AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of December 11, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen provides a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military and veteran healthcare systems. This particular order for the hormone therapy medication reflects the company's ongoing role as a critical supplier for the Defense Health Agency and other federal healthcare programs that rely on the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 12/9/25 |